American College of Rheumatology Annual Meeting

Healio brings you the highlights from the American College of Rheumatology Annual Meeting. Refer back to this page often for the latest news from ACR, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News

One-year delay in diagnosis common for Down syndrome arthropathy

November 29, 2019
ATLANTA — Patients with Down syndrome arthropathy experience a year-long delay from symptom onset to diagnosis, according to a presentation at…
Meeting News

Scarcity of lupus assays in developing countries limit utility of international criteria, trials

November 27, 2019
ATLANTA — Limited access to supportive laboratory assays in developing countries significantly reduces the diagnostic utility of the ACR/EULAR…
Meeting News

RA remission with abatacept, methotrexate best maintained by continued treatment

November 27, 2019
ATLANTA — Among patients with early rheumatoid arthritis who are positive for anti-citrullinated protein antibodies, and achieve remission with…
Meeting News

Lorecivivint yields improved patient-reported outcome scores in knee OA

November 27, 2019
ATLANTA — A 0.07 mg intra-articular injection of lorecivivint, a Wnt pathway inhibitor, was associated with improvements in patient-reported…
Meeting News

TULIP-1: Anifrolumab fails primary endpoint, confers clinical benefit in SLE

November 26, 2019
ATLANTA — Although a 300 mg dose of anifrolumab failed to meet the primary endpoint of systemic lupus erythematosus responder index, a post-hoc…
Meeting News

Novel therapies provide options for patients with spondyloarthritides

November 26, 2019
ATLANTA — Certolizumab pegol and bimekizumab were associated with improvements ranging from work productivity to disease activity in patients…
Meeting News

ADA2 levels elevated in systemic JIA with macrophage activation syndrome

November 26, 2019
ATLANTA — Systemic juvenile idiopathic arthritis with macrophage activation syndrome was marked by elevated adenosine deaminase 2 levels…
Meeting NewsPerspective

Absence of pediatric studies blocking critical biologic DMARDs for JIA

November 25, 2019
ATLANTA — Lax FDA policies on required pediatric studies for approved biologic DMARDs have exacerbated an already critical lack of approved…
Meeting News

Exposure to TNF inhibitors increases psoriasis risk in children with IBD, JIA

November 25, 2019
Children with inflammatory bowel disease, juvenile idiopathic arthritis and chronic noninfectious osteomyelitis had an increased rate of psoriasis…
Meeting News

Gout linked to increased cardiovascular disease risk

November 25, 2019
ATLANTA — Gout is associated with an increased risk for cardiovascular disease, as calculated via population-level cardiovascular risk…